Phreesia, Inc. (NYSE:PHR) CEO Sells $62,768.56 in Stock

Phreesia, Inc. (NYSE:PHR) CEO Chaim Indig sold 2,644 shares of the stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $62,768.56. Following the sale, the chief executive officer now directly owns 1,219,361 shares of the company’s stock, valued at $28,947,630.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Phreesia Stock Up 0.7 %

Phreesia stock traded up $0.17 during trading hours on Wednesday, hitting $24.53. The company had a trading volume of 560,740 shares, compared to its average volume of 497,114. The firm has a market capitalization of $1.41 billion, a P/E ratio of -11.30 and a beta of 0.93. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.76 and a quick ratio of 1.76. The firm’s fifty day moving average is $21.11 and its 200-day moving average is $23.06. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $33.82.

Phreesia (NYSE:PHR) last posted its earnings results on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.16. The company had revenue of $101.20 million during the quarter, compared to the consensus estimate of $100.94 million. Phreesia had a negative net margin of 31.87% and a negative return on equity of 46.89%. The company’s revenue for the quarter was up 20.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.70) earnings per share. On average, research analysts forecast that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on PHR. Canaccord Genuity Group cut their price target on shares of Phreesia from $37.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 31st. Truist Financial restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Monday, July 1st. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a report on Thursday, March 21st. KeyCorp cut their price target on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Friday, May 31st. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and a consensus target price of $30.54.

Institutional Trading of Phreesia

Several large investors have recently added to or reduced their stakes in PHR. International Assets Investment Management LLC boosted its holdings in shares of Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after buying an additional 1,411 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock worth $107,148,000 after buying an additional 194,035 shares during the period. Brown Advisory Inc. boosted its holdings in shares of Phreesia by 22.2% during the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after buying an additional 716,374 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Phreesia by 11.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,757 shares of the company’s stock worth $295,000 after buying an additional 1,324 shares during the period. Finally, TimesSquare Capital Management LLC boosted its holdings in shares of Phreesia by 12.2% during the 4th quarter. TimesSquare Capital Management LLC now owns 868,850 shares of the company’s stock worth $20,114,000 after buying an additional 94,771 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.